Singular Genomics ( NASDAQ: OMIC ) on Friday announced that on June 26, 2024, at 12:01 AM Eastern Time, it will effectuate a 1-for-30 reverse split of its common stock. The company added that the reverse stock split is intended to enable it to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq. Press release.
More on Singular Genomics Systems Singular Genomics Systems, Inc. (OMIC) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Singular Genomics Systems Historical earnings data for Singular Genomics Systems Financial information for Singular Genomics Systems.
